Ermenegildo Zegna N.V (ZGN) concluded trading on Thursday at a closing price of $8.6, with 3.54 million shares of worth about $30.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -2.16% during that period and on June 26, 2025 the price saw a loss of about -2.38%. Currently the company’s common shares owned by public are about 252.58M shares, out of which, 55.08M shares are available for trading.
Stock saw a price change of -5.08% in past 5 days and over the past one month there was a price change of 1.06%. Year-to-date (YTD), ZGN shares are showing a performance of -27.61% which increased to 4.12% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.05 but also hit the highest price of $11.96 during that period. The average intraday trading volume for Ermenegildo Zegna N.V shares is 1.06 million. The stock is currently trading -1.22% below its 20-day simple moving average (SMA20), while that difference is up 3.62% for SMA50 and it goes to 4.31% higher than SMA200.
Ermenegildo Zegna N.V (NYSE: ZGN) currently have 252.58M outstanding shares and institutions hold larger chunk of about 11.93% of that.
The stock has a current market capitalization of $3.51B and its 3Y-monthly beta is at 0.74. PE ratio of stock for trailing 12 months is 26.22, while it has posted earnings per share of $0.33 in the same period. Its PEG reads 1.38 and has Quick Ratio of 0.80 while making debt-to-equity ratio of 1.13. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ZGN, volatility over the week remained 3.59% while standing at 2.83% over the month.
Stock’s fiscal year EPS is expected to rise by 19.93% while it is estimated to increase by 18.84% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by TD Cowen on February 18, 2025 offering a Hold rating for the stock and assigned a target price of $10 to it. On November 22, 2024, Morgan Stanley Initiated their recommendations, while on September 23, 2024, BofA Securities Downgrade their ratings for the stock with a price target of $9.80. Stock get a Buy rating from Goldman on January 11, 2024.
